Manitoba Representation at #CCRC2023 (Hrubeniuk, Briek, Katyal)

The Manitoba Tomorrow Project will be well represented at the Canadian Cancer Research Conference. Dr. Sachin Katyal is an Associate Professor at the University of Manitoba, Senior Scientist at CancerCare Manitoba Research Institute, and Director of the Manitoba Tumour Bank. Dr. Katyal is the Manitoba Tomorrow Project representative on the CanPath National Strategic Advisory Council. Read more about Manitoba Representation at #CCRC2023 (Hrubeniuk, Briek, Katyal)[…]

CSEB Conference Update

The CanPath team was well represented at the Canadian Society for Epidemiology & Biostatistics (CSEB) Conference in Halifax on June 26-28, 2023. We had representatives from the CanPath National Coordinating Centre, Atlantic PATH, CARTaGENE, the Manitoba Tomorrow Project, and the Ontario Health Study that showcased the groundbreaking research and resources available related to epidemiology and biostatistics within CanPath and the regional cohorts. Read more about CSEB Conference Update[…]

CanPath Representation at the Canadian Society for Epidemiology and Biostatistics Conference

We’re so glad to have representation from Atlantic PATH, CARTaGENE, Manitoba Tomorrow Project, Ontario Health Study, and CanPath at the Canadian Society for Epidemiology and Biostatistics Conference in Halifax this week! CanPath and the regional cohorts are well represented in the following sessions: Monday, June 26, 2023 Workshop 1 – Mentorship for Junior Faculty and Funding Read more about CanPath Representation at the Canadian Society for Epidemiology and Biostatistics Conference[…]

Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19

Dr. Victoria Kirsh presented at a CanPath webinar this week to present results from the SUPPORT-Canada study, funded by the federal COVID-19 Immunity Task Force (CITF). Data and blood spot samples were used from 22,300 participants from Atlantic PATH, CARTaGENE, the Ontario Health Study, Manitoba Tomorrow Project, Alberta’s Tomorrow Project, and BC Generations. Key findings include: Read more about Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19[…]